Menu
Home
News
Open submenu
About MedNous
Open submenu
Research Directory
Open submenu
Contact Us
Open submenu
Close submenu
News
News
Appointments
Events
Close submenu
About MedNous
Who We Are
Editorial Board
Editorial Policy
Close submenu
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Close submenu
Contact Us
Contact Form
Skip to main content
2 June 2025
Last updated:
Thursday 29 May 2025
User account anon menu
Login
Register and subscribe
Search
Home
News
News
Appointments
Events
About MedNous
Who We Are
Editorial Board
Editorial Policy
Research Directory
Research Directory
Organisations
Interviewees
Terms
Topics
Contact Us
Contact Form
Menu
Breadcrumb
Home
Research Directory
Research Directory
Multiple ways to genetically alter T cells
Read more
The sky is the limit as Celgene invests in Juno
Read more
Assessing regulatory T cells as therapy
Read more
Engineered cell therapies - the cutting edge
Read more
New agents fight B-cell malignancies
Read more
Gently pushing the accelerator in cancer
Read more
Commentary: Why checkpoint inhibitors need help
Read more
Checkpoint inhibitors - A new horizon for cancer therapy
Read more
Novartis invests in genetically-engineered T cells
Read more
Pagination
First page
« First
Previous page
‹‹
Page
1
Current page
2
Close menu